Soligenix Reports Q3 Results, Makes Steady Progress With Oral BDP Drugs

Soligenix reports Q3 results, makes steady progress with oral BDP drugs

Filed under: drug treatment news articles

The company also recently formed a scientific advisory board to help in the development of its OrbeShield radiation drug for the treatment of gastrointestinal acute radiation syndrome (GI-ARS). For the third quarter, revenue amounted to $ 931,627 …
Read more on Proactive Investors USA & Canada


Why Antares Pharma Will Be A Powerhouse In The Future

Filed under: drug treatment news articles

What I would like to accomplish with this article is to show the average investor why I think Antares Pharma (ATRS) is a long-term winner of a stock. First of all, let me emphasize that I am … The CEO of Antares, Mr. Paul Wotton, has elected to take …
Read more on Seeking Alpha


NewLink Genetics Receives European Orphan Designation for Algenpantucel-L

Filed under: drug treatment news articles

"As emphasized during National Pancreatic Cancer Awareness Month in November, there is a desperate need for new treatment options for this disease and the European Commission's decision to grant orphan drug designation to algenpantucel-L should help us …
Read more on Sacramento Bee


Leave a Reply

Your email address will not be published. Required fields are marked *